Ims Capital Management Abbott Laboratories Transaction History

Ims Capital Management

$213 Million
Q1 2024

A detailed history of Ims Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Ims Capital Management holds 10,592 shares of ABT stock, worth $1.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

10,592

Previous 10,626 0.32%

Holding current value

$1.1 Million

Previous $1.17 Million 2.91%

% of portfolio

0.56%

Previous 0.58%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 12, 2024	SELL	$109.52 - $120.96 $3,723 - $4,112	-34 Reduced 0.32%	10,592 $1.2 Million
Q4 2023 Apr 01, 2024	SELL	$90.19 - $110.4 $9,830 - $12,033	-109 Reduced 1.02%	10,626 $1.17 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $3,821 - $4,584	-40 Reduced 0.37%	10,735 $1.04 Million
Q1 2023 Sep 13, 2023	BUY	$96.86 - $114.01 $7,264 - $8,550	75 Added 0.7%	10,775 $1.09 Million
Q4 2022 Feb 22, 2023	BUY	$95.06 - $111.52 $10,741 - $12,601	113 Added 1.07%	10,700 $1.17 Million

Q3 2022 Nov 17, 2022	BUY	$96.76 - $112.03 $34,349 - $39,770	355 Added 3.47%	10,587 $1.02 Million
Q2 2022 Jul 13, 2022	BUY	$102.07 - $123.37 $28,477 - $34,420	279 Added 2.8%	10,232 $1.11 Million
Q1 2022 Apr 08, 2022	BUY	$114.02 - $139.04 $55,299 - $67,434	485 Added 5.12%	9,953 $1.18 Million
Q4 2021 Jan 05, 2022	BUY	$115.53 - $141.46 $124,772 - $152,776	1,080 Added 12.88%	9,468 $1.33 Million
Q3 2021 Oct 07, 2021	BUY	$116.66 - $129.06 $17,499 - $19,359	150 Added 1.82%	8,388 $991,000
Q2 2021 Jul 07, 2021	BUY	$105.79 - $124.53 $30,255 - $35,615	286 Added 3.6%	8,238 $955,000
Q1 2021 Apr 22, 2021	BUY	$108.84 - $128.23 $16,870 - $19,875	155 Added 1.99%	7,952 $953,000
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $618,975 - $674,505	-5,895 Reduced 43.05%	7,797 $854,000
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $26,667 - $32,385	-291 Reduced 2.08%	13,692 $1.49 Million
Q2 2020 Jul 15, 2020	BUY	$76.57 - $98.0 $356,356 - $456,092	4,654 Added 49.89%	13,983 $1.28 Million
Q1 2020 Apr 03, 2020	SELL	$62.82 - $91.86 $122,499 - $179,127	-1,950 Reduced 17.29%	9,329 $736,000
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $216,609 - $241,136	-2,759 Reduced 19.65%	11,279 $980,000
Q3 2019 Oct 09, 2019	SELL	$81.84 - $88.74 $6,956 - $7,542	-85 Reduced 0.6%	14,038 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $19,021 - $22,185	261 Added 1.88%	14,123 $1.19 Million
Q1 2019 May 21, 2019	SELL	$66.22 - $80.06 $9,535 - $11,528	-144 Reduced 1.03%	13,862 $1.11 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $108,108 - $122,471	-1,649 Reduced 10.53%	14,006 $1.01 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $16,965 - $20,467	-279 Reduced 1.75%	15,655 $0
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $119,285 - $131,654	-2,072 Reduced 11.51%	15,934 $972,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $58,457 - $62,584	-1,089 Reduced 5.7%	18,006 $1.03 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $917,705 - $1.02 Million	19,095	19,095 $1.02 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Ims Capital Management with notifications on news.

Account

Ims Capital Management Abbott Laboratories Transaction History